Creative Biostructure to Present at BPS 2026 Annual Meeting
Creative Biostructure to Present at BPS 2026 Annual Meeting Moscone Center, 747 Howard Street, San Francisco, California 94103, USA February 22-24, 2026 | Booth #613
Learn More >
Close
Leave a Message
My Cart ()
Inquiry Basket
Contact Us

COVID-19 VLP (M; S; E Proteins)(CBS-V952)

Inquiry
Product Summary
Name COVID-19 VLP (M; S; E Proteins)
Download Datasheet
Cat No. CBS-V952
Source Insect cell recombinant
Virus Name SARS-CoV-2
Virus Family Coronaviridae
Composition Spike (S), envelope (E) and membrane (M) proteins
Purity 85%
Presentation 20mM Tris-Cl, pH7.9, 100mM NaCl and 0.5mM EDTA.
Description Recombinant SARS-CoV-2 VLP that comprising Spike (S), envelope (E) and membrane (M) proteins was expressed from insect cells.The VLPs were purified by a combination of gradient centrifugation and chromatographic methods.

Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Frequently Asked Questions Frequently Asked Questions

  • What expression systems do you use for your VLP products?

    Our virus-like particles are produced from different expression systems such as E. coli, yeast, insect cells, and HEK293 cells.

Inquiry
back to top